First Trust Advisors LP raised its stake in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 10.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,051,697 shares of the real estate investment trust’s stock after purchasing an additional 99,537 shares during the period. First Trust Advisors LP owned 0.29% of Medical Properties Trust worth $15,681,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in the business. Massachusetts Financial Services Co. MA grew its holdings in Medical Properties Trust by 2.1% during the third quarter. Massachusetts Financial Services Co. MA now owns 21,516,682 shares of the real estate investment trust’s stock valued at $320,814,000 after purchasing an additional 448,361 shares during the last quarter. Balasa Dinverno & Foltz LLC grew its holdings in Medical Properties Trust by 10.4% during the third quarter. Balasa Dinverno & Foltz LLC now owns 62,335 shares of the real estate investment trust’s stock valued at $929,000 after purchasing an additional 5,864 shares during the last quarter. Oakbrook Investments LLC grew its holdings in Medical Properties Trust by 34.1% during the third quarter. Oakbrook Investments LLC now owns 22,800 shares of the real estate investment trust’s stock valued at $340,000 after purchasing an additional 5,800 shares during the last quarter. Aperio Group LLC grew its holdings in Medical Properties Trust by 30.7% during the third quarter. Aperio Group LLC now owns 751,178 shares of the real estate investment trust’s stock valued at $11,200,000 after purchasing an additional 176,373 shares during the last quarter. Finally, Essex Investment Management Co. LLC acquired a new position in Medical Properties Trust during the third quarter valued at approximately $921,000. Institutional investors own 77.17% of the company’s stock.
MPW has been the topic of several analyst reports. ValuEngine upgraded Medical Properties Trust from a “hold” rating to a “buy” rating in a report on Saturday. Zacks Investment Research upgraded Medical Properties Trust from a “sell” rating to a “hold” rating in a report on Wednesday. Stifel Nicolaus set a $14.00 price target on Medical Properties Trust and gave the company a “hold” rating in a report on Thursday, November 1st. JMP Securities set a $16.00 price target on Medical Properties Trust and gave the company a “buy” rating in a report on Monday, October 1st. Finally, Mitsubishi UFJ Financial Group increased their price target on Medical Properties Trust to $15.00 and gave the company a “neutral” rating in a report on Friday, November 2nd. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $14.19.
In other news, insider Emmett E. Mclean sold 100,000 shares of the firm’s stock in a transaction on Wednesday, August 22nd. The shares were sold at an average price of $14.93, for a total value of $1,493,000.00. Following the sale, the insider now owns 963,965 shares in the company, valued at $14,391,997.45. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Michael G. Stewart sold 12,400 shares of the firm’s stock in a transaction on Friday, October 12th. The stock was sold at an average price of $14.13, for a total value of $175,212.00. Following the completion of the transaction, the director now directly owns 231,039 shares of the company’s stock, valued at $3,264,581.07. The disclosure for this sale can be found here. In the last 90 days, insiders sold 127,400 shares of company stock worth $1,890,812. 0.83% of the stock is currently owned by corporate insiders.
Shares of Medical Properties Trust stock opened at $16.72 on Friday. The firm has a market capitalization of $5.96 billion, a PE ratio of 12.39, a P/E/G ratio of 3.46 and a beta of 0.47. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.19 and a current ratio of 4.92. Medical Properties Trust, Inc. has a 1 year low of $11.82 and a 1 year high of $16.85.
Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings data on Thursday, November 1st. The real estate investment trust reported $0.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.01. The business had revenue of $197.00 million for the quarter, compared to the consensus estimate of $192.64 million. Medical Properties Trust had a net margin of 124.88% and a return on equity of 9.06%. Medical Properties Trust’s quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter last year, the company posted $0.33 earnings per share. On average, sell-side analysts anticipate that Medical Properties Trust, Inc. will post 1.37 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 11th. Stockholders of record on Thursday, September 13th were paid a $0.25 dividend. The ex-dividend date was Wednesday, September 12th. This represents a $1.00 annualized dividend and a dividend yield of 5.98%. Medical Properties Trust’s payout ratio is 74.07%.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
See Also: Rule of 72
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.